Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.

Perera TPS, Jovcheva E, Mevellec L, Vialard J, De Lange D, Verhulst T, Paulussen C, Van De Ven K, King P, Freyne E, Rees DC, Squires M, Saxty G, Page M, Murray CW, Gilissen R, Ward G, Thompson NT, Newell DR, Cheng N, Xie L, Yang J, Platero SJ, Karkera JD, Moy C, Angibaud P, Laquerre S, Lorenzi MV.

Mol Cancer Ther. 2017 Jun;16(6):1010-1020. doi: 10.1158/1535-7163.MCT-16-0589. Epub 2017 Mar 24.

2.

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.

Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK.

Breast Cancer (Dove Med Press). 2016 Feb 3;8:13-27. doi: 10.2147/BCTT.S92414. eCollection 2016.

3.

Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin.

De Schepper S, Bruwiere H, Verhulst T, Steller U, Andries L, Wouters W, Janicot M, Arts J, Van Heusden J.

J Pharmacol Exp Ther. 2003 Feb;304(2):881-8.

PMID:
12538846
4.

Automated beta galactosidase activity bioassay for adult Daphnia magna versus classic immobilization test.

Weltens R, Vanderplaetse F, Vangenechten C, Verhulst T.

Bull Environ Contam Toxicol. 2000 Aug;65(2):139-46. No abstract available.

PMID:
10885989

Supplemental Content

Loading ...
Support Center